Acupuncture care delivered pragmatically as an adjunct to conventional care may lead to improvements in quality of life and alleviation of conventional treatment-related side effects among breast cancer patients. Patient perceptions and expectations of treatment and the therapeutic relationship inherent to acupuncture care could modify treatment effects. The aim of this study was to design a rigorous feasibility study in preparation for trial to evaluate the effects of acupuncture care (a whole system) on the fatigue experienced by patients undergoing conventional treatment of their breast cancer. Phase 1 included the development of a treatment protocol for a short course of acupuncture care for patients with breast cancer undergoing chemotherapy. Defining best practice in this context will ensure that the intervention tested will have meaning and validity for all professional acupuncturists. Phase 2 will be a randomized feasibility pilot study using the acupuncture treatment protocol for 40 patients with breast cancer undergoing chemotherapy. The study will use a mixed-methods approach involving both qualitative and quantitative assessments. Outcome assessment will include validated measures for fatigue, quality of life, and depression. The proposed study will tell us what effects of acupuncture care are important to the patient and address acupuncture as it is practiced in the real world. Results from this study will enable a definitive randomized controlled trial to evaluate the effectiveness of acupuncture care for fatigue in breast cancer patients undergoing chemotherapy.
Breast cancer patients report multiple symptoms while undergoing conventional care including nausea/ vomiting, fatigue, pain, depression, and anxiety. These symptoms affect the quality of life of these patients; the limitations of existing interventions to address these common side effects of treatment are well documented. [1] [2] [3] Patients diagnosed with cancer frequently seek complementary and alternative medicine (CAM) therapy as an adjuvant treatment to their conventional care, and in those diagnosed with breast cancer, CAM use may be as high as 53%. 4 Such care may be delivered in the community (privately or via a voluntary sector cancer support center) or within the National Health Service (eg, via a McMillan Centre attached to an oncology unit). Patients and clinicians would like more information on the effectiveness and safety of complementary interventions. 5 Exploring the potential of acupuncture as an adjunct to conventional care may lead to improvements in quality of life and alleviation of conventional treatment-related side effects, most notably fatigue, among breast cancer patients.
Background
Some of the recent debate about whether acupuncture works centers on its point specificity and whether real acupuncture provides a significantly superior clinical outcome to sham or minimal acupuncture. 6, 7 There is continuing tension within current acupuncture research methodology between pragmatic studies, which measure whole treatment effects, 8, 9 and studies that attempt to define pointspecific efficacy. 10 While there are clear point-specific effects from acupuncture, 7, [11] [12] [13] it is reasonable to argue that the results from any clinical trial may be context dependent. 14, 15 Consequently, creating situations within clinical trials that mirror the real world is more likely to produce effect sizes that are consistent with the real patient experience. 16 Patients may value the whole therapeutic experience of acupuncture substantially more than the point-specific efficacy that acupuncture may create. 6, 11 Within the context of acupuncture as a clinical intervention, acupuncture care as commonly practiced in the Western world today can be best described as using the diagnostic framework and clinical reasoning process inherent to acupuncture and in accordance with traditional Chinese medicine (TCM). 17 It makes it essential in acupuncture diagnosis that the context and descriptive narratives of a patient's illness are listened to and taken together with their individualized signs and symptoms to create a working diagnosis that is influenced by but not restricted to the main complaint. Viewing acupuncture in this context provides model validity 18 and generalizability as far as the intervention is concerned. This process of acupuncture care is best described as a whole system. Investigating it rigorously is best described as whole-systems research (WSR). 19 Part of acupuncture care involves the treatment of disease by the insertion of fine needles along specific meridians, the placement and prescription of which varies depending on the individual presentation and the disease being treated. This offers a different research perspective to point specificity. 20, 21 WSR can also provide insights into conventional medical approaches to illness. The ritual and enormous overall effect size of surgical intervention is a case in point. 22 Surgery is undoubtedly a whole system, and its effects may be far less intervention specific than we currently believe. A simplistic interpretation of the lack of difference between placebo and real intervention suggests that surgery for osteoarthritis of the knee might be purely placebo, linked to prior expectations, but such a view ignores WSR. This type of controlled study 22 may be asking entirely inappropriate questions; the negative outcome is not an argument for abandoning a valuable surgical intervention, but it should make us think about the surgical process and its cultural and contextual meaning.
The question posed dictates the basis for the research methodology that must be employed to answer the specific issues raised by the research question. 23 In this instance, we would like to pose questions that we believe are relevant to the patient's experience while they are having conventional intervention for their breast cancer. To ensure model validity, we need to evaluate the whole system of acupuncture care. It is therefore necessary to design a trial that has the following: Model validity is increased by using outcome measures that are able to capture all or any of the benefits experienced by patients. Using mixed qualitative and quantitative methods will ensure a thorough exploration of the effects of the intervention 3 at the feasibility stage.
Aims and Objectives
Patient perceptions and expectations of treatment, as well as the therapeutic relationship inherent to acupuncture care, could theoretically modify treatment effects. 12 We therefore wish to design a rigorous feasibility study to evaluate the effects of acupuncture care (a whole system) on the fatigue experienced by patients undergoing conventional treatment of their breast cancer. The aim of the study will be to identify the following:
• a flexible treatment protocol that has the support of practitioners currently working in the field as well as experts and that can be applied with reasonable consistency in a trial; • the performance of standard fatigue measures in this patient group and an estimate of the overall effect size of acupuncture care in this context, with respect to fatigue; • further outcome measures that reflect the concerns of patients; and • the feasibility and acceptability of the study design with respect to all stakeholders, including patients, acupuncturists, and those referring into acupuncture care.
We also wish to identify the most appropriate and effective referral patterns for such a study and monitor the safety of the intervention. In a larger study, to address the issue of randomization and the effect it may have on outcome, a comparison will be made of outcomes between patients who choose acupuncture care as an intervention and those who have no preference and can be randomized to treatment. Outcomes can vary between nonrandomized groups whose preference is for the intervention and subjects who have no preference and are randomized. 15 This approach is in keeping with the framework proposed by the Medical Research Council for developing trials of complex interventions, which recommends preference trials as a way of reducing bias at randomization. 24 In this smaller feasibility study, patients will be asked about their treatment preferences at baseline, and this information will be included in the final analysis.
Literature Review
Existing evidence to support the use of acupuncture in this context includes numerous studies exploring the effect of acupuncture therapy on chemotherapyinduced nausea and vomiting. A Cochrane metaanalysis of these studies is currently under way. 25 
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There is considerable evidence that acupuncture is effective in pain relief. 5 Most studies, as evidenced by several Cochrane reviews for different types of acupuncture and different kinds of pain, are poorly designed or too small in size to offer any conclusive evidence. However, a rigorous randomized controlled trial using auricular acupuncture for pain relief in cancer patients found clear evidence of efficacy. 26 The experience of fatigue in women receiving chemotherapy for early-stage breast cancer has been found to be significantly worse than that of agematched controls 27 and is identified as being the most common and most problematic side effect. 28, 29 Currently, aside from treating those patients diagnosed with anemia, there is little treatment to offer people suffering from fatigue. 30 Evaluating the effect of acupuncture therapy on postchemotherapy fatigue has been undertaken in a phase 2 pilot study with cancer patients more than 2 years, on average, after their last chemotherapy treatment. 31 Although the treatment is described as based on TCM, a fixed-point standard prescription was used for every patient; the points were chosen from one textbook using points that were indicated as appropriate in the treatment of fatigue. We would not consider this either traditional Chinese medicine or best practice as far as acupuncture care is concerned and believe it has therefore limited model validity. This study assessed fatigue before and after acupuncture treatment using the Brief Fatigue Inventory (BFI) 32 with no control group.
The symptoms of depression and fatigue can be difficult to differentiate. 33, 34 A study involving breast cancer patients (some of whom suffered from depression and some from fatigue) showed that only those suffering from depression responded to antidepressant therapy. 35 In another study exploring psychologic distress and cancer-related fatigue, the fatigue score was the only significant explanatory variable, suggesting that levels of fatigue experienced by the patient directly affect emotional distress and not vice versa. 36 Currently, a feasibility study exploring the effect of acupuncture care on depression, using a flexible treatment protocol and TCM, is under way, having found in an initial case series the subject worthy of further investigation. 37 This study, however, is not specific to cancer patients who are likely to have different needs from those in the general population who are suffering from depression.
Development of Proposal
In the first instance, it was necessary to identify who the stakeholders would be and set up a team to pool ideas. This first team included a breast cancer consultant oncologist, a TCM acupuncturist/researcher, and 2 senior academics with extensive experience in CAM research. The first draft of the feasibility study was developed and sent for peer review by 2 subgroups within the National Cancer Research Institute. This process of peer review enabled important and essential comments from patient representatives to be included in the design and for the development of an advisory group including patient representatives. After further comment and revision, a 2-phase study was submitted for funding.
Detailed Research Plan Phase 1: Development of a Treatment Protocol for a Short Course of Acupuncture Care for Patients With Breast Cancer Undergoing Chemotherapy, for Use in a Clinical Trial
Protocols exist in China that follow broad prescription patterns according to individual clinical signs and patient-reported symptoms, 38 but treatment protocols for acupuncture care for cancer patients have not been published in the United Kingdom, and little is currently known about the range of approaches and interventions being used by acupuncturists treating this group of patients. Because of the substantial lack of rigorous evidence in this area, we feel it is essential to define consensus in this context, that is, for women undergoing chemotherapy for breast cancer in the United Kingdom. This will ensure that the intervention tested will have meaning and validity for professional acupuncturists. This process of consensus building and flexible, manualized protocol development is being undertaken for Chinese medicine elsewhere for diseases such as endometriosis (A. Flower and G. Lewith, unpublished data, 2006 ) and for Chinese medicine diagnostic processes. 39 Using a panel of practitioners and selected oncology and acupuncture experts, and combined with a literature review, a consensus-building process will be undertaken using Delphi methods 40 to facilitate the development of an agreed treatment protocol for use in research with this patient group. For the Delphi exercise, key features of a possible protocol will be identified and approved in an iterative process until a protocol is refined and consensus achieved. This exercise will be undertaken using electronic communication, thus allowing experts from any location to participate. It is likely that this protocol will contain core procedures plus a degree of flexibility to allow individualization of treatments to suit patient needs. Such flexible protocols support the transferability of acupuncture trial results while ensuring the credibility of the intervention by the replication of acupuncture care as it is practiced in a real-world context. 41, 42 Although acupuncture has an excellent safety record, 43 it is important to establish safety guidelines (including inclusion and exclusion criteria) for this more vulnerable group of patients 44 and to develop agreed methods for monitoring safety within any future research. The Delphi process will also be used to develop reporting mechanisms and safety guidelines, including the identification of an agreed set of patient exclusion criteria.
Phase 2: Pilot Study
To test the agreed protocol in practice, we will undertake a randomized feasibility study using acupuncture treatment for patients with breast cancer undergoing chemotherapy. The design is a comparison between the acupuncture care intervention plus usual care and usual care alone. The decision not to use a sham acupuncture control group has been made because one of the main aims of this pragmatic study is to find the overall clinical effect size of acupuncture care in this context. We feel that the whole package of acupuncture care must be evaluated as we suspect that the individual components of treatment such as point prescription and point specify have been mistakenly (and with little evidence) assumed to account for all the clinical effects within acupuncture and that, therefore, the effects of this intervention have been misunderstood and not adequately evaluated. We feel that the process of WSR challenges these component-led assumptions and is more in line with patient and practitioner experience. The effect sizes derived from this study will allow us to estimate the numbers required to recruit for a larger definitive pragmatic randomized controlled trial that we hope will evaluate both the clinical and economic benefit of this integrated wholesystem approach.
Subjects
Patients who meet agreed inclusion and exclusion criteria would access acupuncture treatment via a referral from the oncologist offered during a clinic consultation before the commencement of their chemotherapy. Likely inclusion criteria will be female, 18 years or older, early-stage breast cancer, and no previous chemotherapy. Likely exclusion criteria will include patients with needle phobia and patients with metastatic cancer or inflammatory cancer. The oncologist will recruit the patient approximately 1 week after their initial consultation to allow patients time to adjust to their conventional care program. The patient information sheet will be developed in close collaboration with consumer representatives on the research advisory board. Patients will be asked if they have a preference for acupuncture treatment.
Sample Size Estimation
A series of 45 consecutive patients who meet the criteria and agree to participate will be randomized to intervention (usual care plus acupuncture care) or control group (usual care). We have estimated a 10% attrition rate and feel that this sample size will be feasible (within time and budget constraints) and will allow for an estimate of the standard deviation and distribution of scores to enable a power calculation to inform the main study and comparison with the literature.
Treatment
Patients will remain under the care of their oncologist at all times. Acupuncture care will be provided by 1 of 2 qualified acupuncturists, who are members of the British Acupuncture Council and who have at least 3 years postqualification clinical experience; care will be delivered in accordance with best practice guidelines and endorsed via the consensus-building phase of the study. Individuals will receive a fixed maximum number of treatments over a period of 14 weeks, starting within a week of their first chemotherapy treatment cycle.
Treatment details, responses to treatment, and adverse events will be monitored using schedules based on those developed for use in a recent UK trial of acupuncture care for patients with low-back pain. 5 Details of acupuncture care will be reported according to the Standards for Reporting Interventions in Controlled Trials of Acupuncture. 45
Outcome Assessment
Fatigue will be assessed through 4 validated outcome measures and through qualitative interviews. Outcome measures will be administered at baseline and after completion of treatment. These measures have been selected to reflect the range of likely benefits and have been used in published studies of acupuncture and cancer.
Fatigue
The BFI 32 has been selected as the primary outcome measure for testing changes in fatigue. It is widely used in cancer care, shows good reliability (Cronbach α = .96), and is relatively simple to complete. It has also been used in a postchemotherapy fatigue and acupuncture study. 30 The BFI consists of 9 items on a 10-point scale, and the BFI score is the mean of the completed items.
Quality of Life
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire and Specific Breast Cancer subscale (EORTC QLQ-C30 and QLQ-BR23) are chosen for the reliability and generalizability for this specific cancer patient group. It will be essential to have the potential to capture any possible benefits patients may or may not experience from receiving acupuncture therapy. As this measure will be taken at baseline and at the end of the study, correlations with the other outcome measures may provide more insight into the experiences of the patient group. In addition, we propose to include the Measure Yourself Medical Outcome Profile (MYMOP) measure. 46 MYMOP is a patient-generated measure in which the patients nominate 2 symptoms that are important to them as well as an activity that their health currently affects. This seems appropriate in an exploratory study and might identify symptoms of concerns that are not covered by the standardized instruments. In addition, MYMOP has been shown to be sensitive to changes patients experience during acupuncture treatment over time.
Depression
The Hospital Anxiety and Depression Scale will be used to measure any feelings of depression at baseline and follow-up. This will enable the relationship between depression and fatigue to be further explored.
Other Outcome Measures
Acupuncture is already widely known for its therapeutic role in alleviating symptoms of nausea and vomiting, and a meta-analysis is being conducted to assess efficacy. These symptoms will be recorded on the EORTC QLQ-C30 as they arise for each individual. Studies being undertaken elsewhere are examining the effect of acupuncture on hot flushes. 47 Outcome measurers will be compared taking into account patients' preferences for treatment at baseline.
The availability of information regarding the use of adjuvant medication such as antidepressants and neutrophil count from the patients' notes will also be explored. This information would enable a comparison of the incidence of neutropenia between the intervention and control groups in a phase 3 study. There is evidence, in both the Chinese literature [48] [49] [50] and in the West, 51 that acupuncture affects leukocytes and granulocytes. The availability of data regarding hemoglobin levels will also be explored to include it in the analysis of the fatigue score as a covariate. 52 Outcome measures will be compared, taking into account patients' preferences for treatment at baseline.
Follow-up Qualitative Study
Semistructured interviews conducted with patients will explore the degree to which the chosen outcome tools measure benefits of relevance to patients and allow them to describe perceived changes over time. This will further elucidate what represents a clinically meaningful change in the fatigue score. Interviews will also be used to explore the patients' perception and experience of acupuncture care and randomization. A minimum of 10 patients will be interviewed on completion of treatment. Patients will be selected for interview according to the principles of purposive sampling to reflect maximum variation in the range of outcomes experienced. Semistructured interviews with all referring oncologists will enable an exploration of beliefs about acupuncture efficacy, the degree to which they were comfortable with making the referral, and the reasons they excluded certain patients. A narrative account of the experiences of the referring oncologist will be highly relevant to the process of recruiting other referring oncologists in any phase 3 study.
Semistructured interviews with the 2 study acupuncturists will explore their experience of delivering care to this group of patients, including the extent to which they felt able to work effectively within the treatment protocol and with the research team. Findings will be used to refine the protocol and to help recruit acupuncturists to a future phase 3 trial.
Conclusion
Acupuncture is a complex intervention that is best understood as a whole system of care. There is evidence that breast cancer patients would benefit from interventions that improve quality of life, including fatigue. Acupuncture has already been found to be beneficial for some symptoms experienced by cancer sufferers. This proposal allows the necessary developmental work to be undertaken in advance of designing a trial that will evaluate the potential contribution of acupuncture care to women undergoing chemotherapy for breast cancer. It will tell us more about the relative importance of fatigue to women in this group and which aspects of acupuncture care are important to the patient. The resulting acupuncture treatment protocol will be defined by expert consensus and as practiced in the real world, ensuring model validity. Statistical results from this study will enable the design of a properly powered randomized controlled trial to test the effectiveness of acupuncture care for fatigue in breast cancer patients undergoing chemotherapy.
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